Within NanoMat three research centers of the Hermann von Helmholtz-Gemeinschaft Deutscher Forschungszentren, ten universities with natural and engineering science departments, one Max Planck Institute, an Institute of the Wissenschaftsgemeinschaft Gottfried Wilhelm Leibniz, three Fraunhofer Institutes, an Institute of the Polish Academy of Science, the DECHEMA and four major companies coordinate their research programmes. The theme of the research is 'Synthesis and investigation of nanostructured metals and ceramics, and investigation of the materials and applications which result from their nanoscale nature.'
In the cluster of excellence Nanosystems Initiative Munich (NIM), scientists from various research facilities in the Munich area in the fields of physics, biophysics, physical chemistry, biochemistry, pharmaceuticals, biology, electronics and medicine work together with the goal of designing, producing and controlling a series of artificial and multifunctional nanosystems.
This German center of competence is coordinated by Fraunhofer-Institute IWS Dresden. It joins 51 enterprises, 10 university institutes, 22 research institutes, and 5 corporations into a common network.
This joint effort gathers a number of leading German research institutions from the Max Planck Society, the Helmholtz Society, and the Fraunhofer Society together with partners from Germany's Photonics industry. The PhoNa consortium conducts research on a broad spectrum of linear and nonlinear Photonic Nanomaterials, as e.g. metamaterials, photonic crystals, plasmonics, diffractive structures, and their application in fields such as biology, chemistry and material sciences.
The goal of the European FP7 VascuBone project is to develop a 'tool box' for bone regeneration, which on one hand fulfils basic requirements and on the other hand is freely combinable with what is needed in the respective patient's situation. The tool box will include a variation of biocompatible biomaterials and cell types, FDA approved growth factors, material modification technologies, simulation and analytical tools like molecular imaging based in vivo diagnostics which can be combined for the specific medical need. This tool box will be used to develop translational approaches for regenerative therapies of three different types of bone defects.